Home > Newsletters > Drug Industry Daily > New Study May Alleviate Sponsor, Regulator Concerns About Foreign Trials
Drug Industry Daily
July 13, 2012 | Vol. 11 No. 137
New Study May Alleviate Sponsor, Regulator Concerns About Foreign Trials
Drugmakers and regulators can be more confident about the rigor of trial data coming from emerging regions as the data quality for studies conducted in developing nations appears to be on par with trials in more research-savvy, developed nations, a new study concludes.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.